Low LIM-domain only 2 (LMO2) expression in aggressive B cell lymphoma correlates with MYC and MYC/BCL2 rearrangements, especially in germinal center cell-type tumors

Citation topics: 1 Clinical & Life Sciences; 1.130 Lymphomas; 1.130.132 Lymphoma
Web Of Science research areas: Hematology; Oncology
ESI research areas: Clinical Medicine

UN Sustainable Development Goals (SDGs)

This output has contributed to the advancement of the following goals:

Source: InCites

Title: Low LIM-domain only 2 (LMO2) expression in aggressive B cell lymphoma correlates with MYC and MYC/BCL2 rearrangements, especially in germinal center cell-type tumors
Creators: Jennifer Chapman - Department of Pathology and Laboratory Medicine, Division of Hematopathology, University of Miami/Sylvester Comprehensive Cancer Center, Miami, FL, USA
Ramiro E Verdun - Department of Medicine, Division of Hematology, University of Miami/Sylvester Comprehensive Cancer Center, Miami, FL, USA
Izidore S Lossos - Department of Medicine, Division of Hematology, University of Miami/Sylvester Comprehensive Cancer Center, Miami, FL, USA
Publication Details: Leukemia & lymphoma, Vol.ahead-of-print(ahead-of-print), pp.1-4
Academic Unit: Miller School of Medicine; UMMG Department of Pathology; UMMG Dept of Medicine - Hematology/Oncology; UMMG Dept of Medicine - Geriatric Medicine and Palliative Care
Language: English
Resource Type: Journal article
PMID: 33988072
Record Identifier: 991031598177602976